Skip to content
Parakho

Corona Remedies Ltd

NSE CORONABSE 544644coronaremedies.com

Q1 FY27, unaudited

Revenue
₹422.43 Cr
Profit after tax
₹60.10 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations422.43—1,403.18
Other income3.15—10.65
Total income425.58—1,413.83
Employee benefit expense122.09—403.02
Finance costs2.69—6.97
Depreciation & amortisation13.24—37.87
Total expenses345.23—1,154.58
Profit before tax80.35—240.15
Tax expense20.25—55.30
Profit after tax60.10—184.85
Total comprehensive income59.80—184.96
Earnings per share
Earnings per share, basic₹9.83₹30.22
Earnings per share, diluted₹9.83₹30.22

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Q1 FY27

CORONA Remedies reported Q1 FY27 revenue growth of 21.9% year-on-year to Rs 422 crores, with EBITDA growing 33.5% and PAT growing 30.1%. Management said the India business grew 22.7%, outperforming the Indian Pharmaceutical Market's 11.6% growth, driven by a mix of volume, pricing and new product launches. The company also commercialized a new EU-GMP approved hormone manufacturing facility during the quarter and reaffirmed its FY27 revenue and profit growth targets.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 53 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.